Analysis of the Onset and Mortality of Common Malignant Tumors Among Registered Residents in Xishan District in 2016
Download PDF

DOI

10.26689/par.v4i1.1144

Submitted : 2020-03-04
Accepted : 2020-03-19
Published : 2020-04-03

Abstract

Objective: To analyse the cancer incidence and mortality in xishan district in 2016, and to provide scientific basis for tumor prevention and control. Methods: The 2016 malignant tumor registration report data in xishan district were collected and analysed, stratified according to gender and age, and the reported incidence of malignant tumor in xishan district was calculated and analysed (all the following incidence rates belong to the reported incidence), gender, age incidence, bid acceptance rate, mortality and other related indicators. Results: The total registered population of malignant tumor in xishan district in 2016 was 540,494 (268 553 males and 271 941 females), and 876 new cases were reported. The incidence rate was 162.07/105, the bid-winning rate was 176.39 /105, the world standard rate was 91.16/105, and the cumulative rate (0-74 years old) was 10.44%. The incidence of malignant tumors in males (159.00/105) was lower than that in females (165.11/105). Incidence increases with age, rises sharply and rapidly around age 40, and declines after reaching a peak at age 75. Lung cancer, colorectal cancer, thyroid cancer and female breast cancer are common malignant tumors in the western mountainous areas. It accounts for about 55% of the total number of new malignant tumors. In 2016, 653 people died of malignant tumors in xishan district. The mortality rate was 120.82/105 (male mortality 151.11/105, female mortality 90.46/105), the bid-winning mortality rate was 43.53/105, and the bid-winning mortality rate was 57.72/105. Lung cancer, liver cancer, colorectal cancer and stomach cancer are the malignant tumors with high mortality, accounting for about 62% of the death. Conclusion: The morbidity and mortality of malignant tumors are relatively high in xishan district, and prevention and control of lung cancer, liver cancer, stomach cancer, colorectal cancer, female breast cancer and thyroid cancer should be emphasized.